Sean Dodge
Stock Analyst at RBC Capital
(2.05)
# 2,902
Out of 4,876 analysts
133
Total ratings
31.96%
Success rate
-2.63%
Average return
Main Sectors:
Stocks Rated by Sean Dodge
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCAT Health Catalyst | Maintains: Sector Perform | $7 → $6 | $3.85 | +56.05% | 10 | Feb 27, 2025 | |
| AGL agilon health | Maintains: Outperform | $3 → $3.5 | $2.35 | +49.25% | 7 | Feb 26, 2025 | |
| IQV IQVIA Holdings | Reiterates: Outperform | $270 | $157.74 | +71.17% | 6 | Feb 10, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $11 → $12 | $8.36 | +43.63% | 16 | Jan 24, 2025 | |
| ICLR ICON Public Limited Company | Reiterates: Outperform | $263 | $145.18 | +81.15% | 2 | Jan 15, 2025 | |
| EVH Evolent Health | Maintains: Outperform | $20 → $17 | $10.98 | +54.83% | 9 | Jan 14, 2025 | |
| PHR Phreesia | Upgrades: Outperform | $24 → $32 | $28.50 | +12.28% | 15 | Jan 8, 2025 | |
| OPRX OptimizeRx | Downgrades: Sector Perform | $7 → $6 | $13.46 | -55.41% | 11 | Jan 8, 2025 | |
| HQY HealthEquity | Maintains: Outperform | $100 → $105 | $105.40 | -0.38% | 12 | Dec 10, 2024 | |
| SHC Sotera Health Company | Reiterates: Outperform | $17 | $11.35 | +49.78% | 10 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $34 | $40.15 | -15.31% | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $23.56 | -40.56% | 3 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $4.96 | +101.61% | 12 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $22.01 | +27.21% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $14 | $14.83 | -5.60% | 13 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $167.70 | -80.32% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $990 → $180 | $0.56 | +32,071.58% | 2 | Mar 9, 2022 |
Health Catalyst
Feb 27, 2025
Maintains: Sector Perform
Price Target: $7 → $6
Current: $3.85
Upside: +56.05%
agilon health
Feb 26, 2025
Maintains: Outperform
Price Target: $3 → $3.5
Current: $2.35
Upside: +49.25%
IQVIA Holdings
Feb 10, 2025
Reiterates: Outperform
Price Target: $270
Current: $157.74
Upside: +71.17%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $11 → $12
Current: $8.36
Upside: +43.63%
ICON Public Limited Company
Jan 15, 2025
Reiterates: Outperform
Price Target: $263
Current: $145.18
Upside: +81.15%
Evolent Health
Jan 14, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $10.98
Upside: +54.83%
Phreesia
Jan 8, 2025
Upgrades: Outperform
Price Target: $24 → $32
Current: $28.50
Upside: +12.28%
OptimizeRx
Jan 8, 2025
Downgrades: Sector Perform
Price Target: $7 → $6
Current: $13.46
Upside: -55.41%
HealthEquity
Dec 10, 2024
Maintains: Outperform
Price Target: $100 → $105
Current: $105.40
Upside: -0.38%
Sotera Health Company
Nov 21, 2024
Reiterates: Outperform
Price Target: $17
Current: $11.35
Upside: +49.78%
Nov 7, 2024
Maintains: Outperform
Price Target: $31 → $34
Current: $40.15
Upside: -15.31%
Sep 17, 2024
Reiterates: Outperform
Price Target: $14
Current: $23.56
Upside: -40.56%
Aug 16, 2024
Reiterates: Outperform
Price Target: $10
Current: $4.96
Upside: +101.61%
Aug 14, 2024
Reiterates: Outperform
Price Target: $28
Current: $22.01
Upside: +27.21%
Jul 25, 2024
Maintains: Outperform
Price Target: $15 → $14
Current: $14.83
Upside: -5.60%
Sep 14, 2022
Initiates: Outperform
Price Target: $33
Current: $167.70
Upside: -80.32%
Mar 9, 2022
Maintains: Sector Perform
Price Target: $990 → $180
Current: $0.56
Upside: +32,071.58%